154 related articles for article (PubMed ID: 24342311)
1. Association of β-adrenergic receptor genes polymorphisms with incidence of subsequent cardiovascular events in Han Chinese patients with coronary artery disease.
Li ZG; Wu H; Zhou YL; Chen ZJ; Meng JX; Yang JQ; Chen JY; Zhong SL
Chin Med J (Engl); 2013; 126(24):4679-84. PubMed ID: 24342311
[TBL] [Abstract][Full Text] [Related]
2. β
Li Y; Yuan H; Sun L; Zhou Q; Yang F; Yang Z; Liu D
Genet Test Mol Biomarkers; 2019 Feb; 23(2):124-137. PubMed ID: 30668166
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.
Castaño-Amores C; Antúnez-Rodríguez A; Pozo-Agundo A; García-Rodríguez S; Martínez-González LJ; Dávila-Fajardo CL
Biomed Pharmacother; 2023 Dec; 169():115869. PubMed ID: 37952358
[TBL] [Abstract][Full Text] [Related]
4. Influence of ADRB1, ADRB2, and COMT Genetic Polymorphisms on Postoperative Outcomes of Patients Undergoing Cardiac Valve Surgery.
Dai S; Ma W; Qin G; Wang L; Wang E
Clin Ther; 2021 Feb; 43(2):349-359.e2. PubMed ID: 33451866
[TBL] [Abstract][Full Text] [Related]
5. Association of β-Adrenergic Receptor Gene Polymorphisms With Acute Coronary Syndrome and Cardiovascular Risk Factors in an Arab Population.
El-Menyar A; Rizk NM; Asim M; Al-Thani H; Elgendy A; Al-Suwaidi J
Angiology; 2016 Sep; 67(8):762-71. PubMed ID: 26602751
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention.
Li ZG; Li G; Zhou YL; Chen ZJ; Yang JQ; Zhang Y; Sun S; Zhong SL
Lipids Health Dis; 2013 Aug; 12():127. PubMed ID: 23978127
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of beta-adrenergic receptors and susceptibility to open-angle glaucoma.
Inagaki Y; Mashima Y; Fuse N; Funayama T; Ohtake Y; Yasuda N; Murakami A; Hotta Y; Fukuchi T; Tsubota K
Mol Vis; 2006 Jun; 12():673-80. PubMed ID: 16785856
[TBL] [Abstract][Full Text] [Related]
8. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
Lanfear DE; Jones PG; Marsh S; Cresci S; McLeod HL; Spertus JA
JAMA; 2005 Sep; 294(12):1526-33. PubMed ID: 16189366
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics and healthcare outcomes in patients with chronic heart failure.
Kim KM; Murray MD; Tu W; Robarge J; Ding Y; Brater DC; Flockhart DA
Eur J Clin Pharmacol; 2012 Nov; 68(11):1483-91. PubMed ID: 22543981
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in Beta-2 Adrenergic Receptor Gene and Association with Tuberculosis.
Azar AF; Jazani NH; Bazmani A; Vahhabi A; Shahabi S
Lung; 2017 Feb; 195(1):147-153. PubMed ID: 27900465
[TBL] [Abstract][Full Text] [Related]
11. Investigating changes in β-adrenergic gene expression (ADRB1 and ADRB2) in Takotsubo (stress) cardiomyopathy syndrome; a pilot study.
Tutgun Onrat S; Dural İE; Yalım Z; Onrat E
Mol Biol Rep; 2021 Dec; 48(12):7893-7900. PubMed ID: 34716504
[TBL] [Abstract][Full Text] [Related]
12. The ADRB1 (Adrenoceptor Beta 1) and ADRB2 genes significantly co-express with commonly mutated genes in prostate cancer.
Lehrer S; Rheinstein PH
Discov Med; 2020; 30(161):163-171. PubMed ID: 33593484
[TBL] [Abstract][Full Text] [Related]
13. beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension.
Pacanowski MA; Gong Y; Cooper-Dehoff RM; Schork NJ; Shriver MD; Langaee TY; Pepine CJ; Johnson JA;
Clin Pharmacol Ther; 2008 Dec; 84(6):715-21. PubMed ID: 18615004
[TBL] [Abstract][Full Text] [Related]
14. Association of the ADRB2 (rs2053044) polymorphism and angiotensin-converting enzyme-inhibitor blood pressure response in the African American Study of Kidney Disease and Hypertension.
Anthony EG; Richard E; Lipkowitz MS; Bhatnagar V
Pharmacogenet Genomics; 2015 Sep; 25(9):444-9. PubMed ID: 26111150
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of the human beta-adrenergic receptors.
Taylor MR
Pharmacogenomics J; 2007 Feb; 7(1):29-37. PubMed ID: 16636683
[TBL] [Abstract][Full Text] [Related]
16. Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patients.
Petersen M; Andersen JT; Hjelvang BR; Broedbaek K; Afzal S; Nyegaard M; Børglum AD; Stender S; Køber L; Torp-Pedersen C; Poulsen HE
Br J Clin Pharmacol; 2011 Apr; 71(4):556-65. PubMed ID: 21395649
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence.
Chu X; Dong Y; Shen M; Sun L; Dong C; Wang Y; Wang B; Zhang K; Hua Q; Xu S; Huang W
BMC Med Genet; 2009 Mar; 10():26. PubMed ID: 19284637
[TBL] [Abstract][Full Text] [Related]
18. [The association between beta-adrenergic receptor gene polymorphisms and personality traits].
Numajiri M; Aoki J; Nishizawa D; Kasai S; Ogai Y; Ikeda K; Iwahashi K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):227-31. PubMed ID: 23012891
[TBL] [Abstract][Full Text] [Related]
19. Adrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner.
Cresci S; Dorn GW; Jones PG; Beitelshees AL; Li AY; Lenzini PA; Province MA; Spertus JA; Lanfear DE
J Am Coll Cardiol; 2012 Sep; 60(10):898-907. PubMed ID: 22703928
[TBL] [Abstract][Full Text] [Related]
20. Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trial.
Petersen M; Andersen JT; Jimenez-Solem E; Broedbaek K; Afzal S; Nyegaard M; Børglum AD; Stender S; Torp-Pedersen C; Køber L; Poulsen HE
Pharmacogenet Genomics; 2012 Oct; 22(10):709-15. PubMed ID: 22760495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
